CHIEF SCIENTIFIC OFFICER CONSULTING AGREEMENTChief Scientific Officer Consulting Agreement • March 23rd, 2020 • Salarius Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 23rd, 2020 Company Industry JurisdictionThis Chief Scientific Officer Consulting Agreement (“Consulting Agreement”) is entered into as of March 6, 2020, by and between Salarius Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Bruce McCreedy, Ph.D. (“Consultant”), effective generally as of the Effective Date (as defined below) except as otherwise expressly provided below.